YANG ARVIN (Chief Medical Officer) sold 17.6% of their position (5.53K shares) of MERSANA THERAPEUTICS, INC. on the open market
Open‑market sale worth $36.4K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/2/2022ACC: 0001104659-22-124083
Officer· Chief Medical Officer
Since Nov 2020
-5.53K
Net shares
Net seller
$36.4K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
18.50K acquired · 24.03K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+18.50K
Price / share
—
Trade value
—
% of position
142.6%
11/30/2022
12.97K→31.47K
Common Stock
Direct
Shares
−5.53K
Price / share
$6.59
Trade value
$36.42K
% of position
17.6%
12/1/2022
31.47K→25.95K
Total
Net shares
+12.97K
Net value
-$36.42K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/30/2022 | M · Option Exercise | +18.50K | — | — | 142.6% | 12.97K | 31.47K |
| Common Stock Direct | 12/1/2022 | S · Sale | −5.53K | $6.59 | $36.42K | 17.6% | 31.47K | 25.95K |
| Total | +12.97K | -$36.42K | ||||||
Derivative Transactions1
Restricted stock unit
Direct
Converts to
Common Stock
18.50K shares
Shares
−18.50K
Strike price
Held after
0.00
Exercisable
—
11/30/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted stock unit Direct | Common Stock18.50K shares | 11/30/2022 | M · Option Exercise | −18.50K | — | 0.00 |